Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation ?

Encephale

Volumn 26, Issue SPEC. ISS. 1, 2000, Pages 7-11

  Blin, O ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Amisulpride; Quality of life; Schizophrenia; Social adaptation

Indexed keywords

DRUG DERIVATIVE; NEUROLEPTIC AGENT; SULPIRIDE; SULTOPRIDE;

ACUTE DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; HUMAN; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SULPIRIDE; TREATMENT OUTCOME;

EID: 1542777808     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. PEUSKENS J, BECH P, MÖLLER HJ, BALE R, FLEUROT O and the AMISULPRIDE STUDY GROUP. Amisulpride versus risperidone in the treatment of acute exacerbations of schizophrenia. Psychiatry Research 88, 1999 : 107-17.
2. COLONNA L, SALEEM P, DONDEY-NOUVEL L, REIN W and the AMISULPRIDE STUDY GROUP. Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. International Clinical Psychopharmacology 2000.
3. COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS. Note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia. Draft 5, January 1997.
4. CARRIERE P, BONHOMME D, LEMPERIERE L. Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia : results of a multiceriter double-blind study (the Amisulpride Study Group). Eur Psychiatry 2000 ; 15 : 321-9.
5. MÖLLER HJ, BOYER P, FLEUROT O, REIN W and the PROD-ASLP STUDY GROUP. Improvement of acute exacerbations of schizophrenia with amisulpride : a comparison with haloperidol. Psychopharmacology 1997 ; 132 : 396-401.
6. PUECH AJ, FLEUROT O, REIN W et al. and the AMISULPRIDE STUDY GROUP. Amisulpride, an atypical antipsychotic in the treatment of acute episodes of schizophrenia : a dose ranging study vs. haloperidol. Acta Psychiatr Scand 1998 ; 98 : 65-72.
7. WETZEL H, GRÜNDER G, HILLERT A et al. and the AMISULPRIDE STUDY GROUP. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology - a double blind controlled study comparing a selective D2-like antagonist to a mixed D1-D2-like antagonist. Psychopharmacology 1998 ; 137 : 223-2.